📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. (2023)

First Author: Portnoy A

Attributed to: Infection prevention and control for drug-resistant tuberculosis in South Africa in the era of decentralised care: a whole systems approach funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1004155

PubMed Identifier: 36693081

Publication URI: http://europepmc.org/abstract/MED/36693081

Type: Journal Article/Review

Volume: 20

Parent Publication: PLoS medicine

Issue: 1

ISSN: 1549-1277